A detailed history of Shell Asset Management CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 6,348 shares of TVTX stock, worth $108,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,348
Previous 6,704 5.31%
Holding current value
$108,741
Previous $55,000 61.82%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$7.89 - $15.21 $2,808 - $5,414
-356 Reduced 5.31%
6,348 $89,000
Q1 2024

Jul 31, 2024

SELL
$7.18 - $9.82 $2,814 - $3,849
-392 Reduced 5.52%
6,704 $55,000
Q1 2024

May 14, 2024

SELL
$7.18 - $9.82 $430 - $589
-60 Reduced 0.84%
7,096 $55,000
Q4 2023

Feb 14, 2024

SELL
$5.44 - $9.5 $11,701 - $20,434
-2,151 Reduced 23.11%
7,156 $64,000
Q3 2023

Nov 08, 2023

SELL
$7.64 - $17.25 $1,123 - $2,535
-147 Reduced 1.55%
9,307 $83,000
Q2 2023

Jul 28, 2023

SELL
$15.3 - $22.61 $826 - $1,220
-54 Reduced 0.57%
9,454 $145,000
Q1 2023

May 15, 2023

SELL
$17.82 - $22.89 $588 - $755
-33 Reduced 0.35%
9,508 $214,000
Q4 2022

Feb 07, 2023

SELL
$18.47 - $26.14 $35,757 - $50,607
-1,936 Reduced 16.87%
9,541 $201,000
Q3 2022

Nov 14, 2022

SELL
$22.91 - $28.63 $68,913 - $86,119
-3,008 Reduced 20.77%
11,477 $283,000
Q2 2022

Aug 09, 2022

BUY
$20.94 - $30.01 $502 - $720
24 Added 0.17%
14,485 $351,000
Q1 2022

May 04, 2022

SELL
$23.61 - $30.6 $50,525 - $65,484
-2,140 Reduced 12.89%
14,461 $373,000
Q4 2021

Feb 09, 2022

BUY
$24.34 - $31.17 $1,801 - $2,306
74 Added 0.45%
16,601 $515,000
Q3 2021

Nov 04, 2021

SELL
$12.98 - $25.03 $9,215 - $17,771
-710 Reduced 4.12%
16,527 $401,000
Q2 2021

Aug 12, 2021

BUY
$14.11 - $26.4 $13,122 - $24,552
930 Added 5.7%
17,237 $251,000
Q1 2021

May 10, 2021

BUY
$23.37 - $31.77 $220,285 - $299,464
9,426 Added 136.99%
16,307 $407,000
Q4 2020

Feb 16, 2021

BUY
$19.17 - $27.87 $131,908 - $191,773
6,881 New
6,881 $188,000

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.1B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.